ML
Mark Lappe bought $2.6M of INBX stock
Mark Lappe, Chief Executive Officer of Inhibrx Biosciences, Inc. (INBX), bought 25,000 shares of INBX stock worth $2.6M, per an SEC Form 4 filed Sep 8, 2026.
It was an open-market purchase.
The trade was reported on Sep 8, 2026.
INBX has moved -35.0% since the trade date, from $114.34 to $74.33 (Nov 19, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 8, 2026
- Filing delay
- 0 days
- Price since
- -35.0%
- Role
- Chief Executive Officer
- Source
- SEC Form 4